Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

3 Penny Stocks to Catapult You Into the Millionaires’ Club

These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up!

Why Is Galmed Pharmaceuticals (GLMD) Stock Moving Today?

Galmed Pharmaceuticals (GLMD) stock is on the move Thursday after the medical company priced a public offering of its shares.

Why Is CryoPort (CYRX) Stock Down 26% Today?

CryoPort (CYRX) stock is falling on Thursday after the cell and gene therapy products company released preliminary results for Q2 2023.

Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 17% Today?

60 Degrees Pharmaceuticals (SXTP) stock is on the rise Thursday following the medical company's public debut on Wednesday!

Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now

These three dangerous biotech stocks are not investable even if you're bullish on the sector overall.

7 Biotech Stocks to Sell in July

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

3 Biotech Stocks to Sell Before They Damage Your Portfolio 

With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point. 

Bargain Hunting: 3 Stocks to Buy at 52-Week Lows

The art of wealth creation by investing hinges on quality bargain stocks to wager on during market downturns

RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring

Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.

Why Is PainReform (PRFX) Stock Down 40% Today?

PainReform (PRFX) stock is falling on Wednesday after the company announced a concurrent registered direct offering and private placement.

Why Is Cadrenal Therapeutics (CVKD) Stock Up 71% Today?

Cadrenal Therapeutics (CVKD) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company.

Why Is Healthcare Triangle (HCTI) Stock Up 124% Today?

Healthcare Triangle (HCTI) stock is rocketing higher on Wednesday despite a lack of news from the healthcare information technology company.

3 Hypergrowth Stocks to Catapult You into the Millionaires’ Club

Which growth stocks can put you in the millionaires' club sooner? These three hypergrowth stocks can make great additions to your portfolio.

3 Biotech Stocks That AI is Loving in July

As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential.

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership

Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk.

Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today?

Iovance Biotherapeutics (IOVA) stock is sliding lower on Tuesday after the company announced details of a public share offering.

Why Is Better Therapeutics (BTTX) Stock Up 39% Today?

Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment.

Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?

CytoMed Therapeutics (GDTC) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning.